Medical AI Alliance
← Company Index
Medical AIKOSDAQ 458870Innovative Medical Device23 approvals

SEERS Co., Ltd.

Official website

Founded in 2009, SEERS provides the wearable ECG analysis solution mobiCARE and the inpatient monitoring solution thynC, based on AI vital-sign analytics.

As of 2026-10-10, SEERS Co., Ltd. has 1 MFDS Innovative Medical Device designation, 21 Korean MFDS device approvals, 1 US FDA clearance/approval, 20 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2009 and listed on KOSDAQ in 2024, SEERS is an IoMT platform company combining AI-based vital-sign analysis with wearable medical devices. It offers the wearable ECG analysis solution mobiCARE (launched July 2020) for arrhythmia screening and diagnosis, and the inpatient vital-sign monitoring solution thynC (launched 2024). As of December 2025, about 1,000 medical institutions nationwide had adopted mobiCARE, with cumulative tests surpassing 620,000, while thynC recorded cumulative installations of 12,000 hospital beds.

Products & technology

  • mobiCAREWearable ECG analysis for arrhythmia screening and diagnosis (subscription service)
  • thynCReal-time inpatient vital-sign monitoring

Regulatory approvals

data.go.kr · openFDA

1 Innovative Medical Device designations · 2025 / 21 Korean MFDS device approvals · 2010–2026 / 1 US FDA 510(k) · 2026

  • InnovativeS-MAPS2025-07-25
    Innovative Medical Device designation
  • FDAmobiCARE Cardiac Monitoring System (mobiCARE-MC200M, mobiCARE-MC200ML, mobiCARE-MC200M7, mobiCARE-MC200ML7)2026-06-25
    510(k) · TraditionalCardiovascularK253384
  • MFDSCuff, blood pressure2026-02-09
    Product approval · Class 1제신 26-184 호
  • MFDSElectrocardiographic Holter analyser2025-12-24
    Product approval · Class 2제인 25-5192 호
  • MFDSProbe, general-purpose, external2025-08-13
    Product approval · Class 1제신 25-1050 호
  • MFDSProduct name not recorded2025-08-07
    Product approval · Class 2인 25-4036 호
  • MFDSPatient monitoring software2023-09-19
    Product approval · Class 2제인 23-5092 호
  • MFDSPulse oximeter, line-powered2023-09-15
    Product approval · Class 2제허 23-926 호
  • MFDSProbe, general-purpose, external2022-11-07
    Product approval · Class 1제신 22-1553 호
  • MFDSProbe, general-purpose, external2022-11-07
    Product approval · Class 1제신 22-1552 호
  • MFDSThermometer, electronic, infrared, skin2022-05-24
    Product approval · Class 2제인 22-4407 호
  • MFDSPatient monitor, central2022-05-16
    Product approval · Class 2제인 22-4379 호
Show 11 more
  • MFDSProduct name not recorded2022-05-16
    Product approval · Class 2인 22-4379 호
  • MFDSElectrode, electrocardiograph, single-use2022-02-15
    Product approval · Class 1제신 22-206 호
  • MFDSU-healthcare gateway software, class 12021-11-10
    Product approval · Class 1제신 21-1490 호
  • MFDSProduct name not recorded2021-11-10
    Product approval · Class 1신 21-1490 호
  • MFDSElectrocardiographic Holter analyser2021-10-01
    Product approval · Class 2제인 21-4840 호
  • MFDSThermometer, electronic, infrared, skin2021-07-05
    Product approval · Class 2제인 21-4576 호
  • MFDSElectrocardiographic Holter analyser2019-08-09
    Product approval · Class 2제인 19-4678 호
  • MFDSU-healthcare gateway, class 12019-04-22
    Product approval · Class 1제신 19-520 호
  • MFDSU-healthcare, sphygmomanometer, automatic-inflation, noninvasiveRevoked2017-04-20
    Product approval · Class 2제허 17-278 호
  • MFDSElectrocardiographic analyser2016-06-27
    Product approval · Class 2제인 16-4537 호
  • MFDSU-healthcare gateway, class 1Revoked2010-11-03
    Product approval · Class 2제허 10-1125 호

Global clinical trials

ClinicalTrials.gov · sponsor-matched

R&D and key agreements

Source: DART corporate disclosure

웨어러블 의료기기 다양화 · Development and domestic certification of vital-sign measuring devices including thermometer, pulse oximeter, and blood pressure monitor

심전도 분석 솔루션 고도화 · Improving arrhythmia detection accuracy and developing predictive algorithms

MCT 솔루션 개발 · Securing real-time outpatient ECG monitoring technology to meet US medical device approval standards

재택환자모니터링 솔루션 개발 · Developing home monitoring solutions for discharged post-surgical patients, validated through clinical trials

Key disclosures

KRX KIND via OpenDART

Publications

PubMed · affiliation-matched
Show 10 more publications

Patents

KIPRIS · applicant-matched
Show 98 more patents

AI reads

MAA server logs · IP-verified
106
Times AI engines pulled SEERS Co., Ltd.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

6
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

100
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

15
live 2
Last 7 days
88
live 6
Last 30 days
106
live 6
All time
  • OpenAIChatGPT-Userlive6
  • OpenAIOAI-SearchBot85
  • GoogleGoogleOther8
  • PerplexityPerplexityBot5
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 4 AI engines · last read Oct 10, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for SEERS Co., Ltd. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview. Send us materials and we will add them

Companies approved for the same productsMedical AI

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

MEDIANA Co.,LTD8 shared

Founded in 1995 and listed on KOSDAQ in 2014, Mediana is a hospital medical device maker developing and manufacturing patient monitors and automated external defibrillators under its own brand and via ODM.

MEZOO Co., Ltd.7 shared

KOSDAQ-listed medical device company developing the HiCardi wearable patch-type patient monitor.

MEKICS Co., Ltd6 shared

KOSDAQ-listed critical-care medical device company manufacturing ventilators, the OmniOx respiratory therapy device series, and patient monitors.

CU MEDICAL SYSTEMS Inc.5 shared

Founded in 2001 and KOSDAQ-listed in 2011, CU Medical Systems makes AEDs and other emergency medical devices.

Sky Labs Inc.4 shared

Ring-type cuffless blood pressure monitors and a platform that turns everyday physiological signals into clinical data.

VUNO, Inc.3 shared

Founded in 2014, VUNO provides AI-based vital-sign and medical imaging diagnostic solutions, including VUNO Med-DeepCARS and VUNO Med-Fundus AI.

BIO PROTECH INC.3 shared

Manufactures biosensors for electronic medical device consumables, including ECG measurement electrodes.

BITComputer2 shared

Founded in 1985, BITComputer provides hospital information systems such as bitnixHIS and CLEMR, alongside digital healthcare and IT education businesses.

SEWOONMEDICAL CO,. LTD.2 shared

Founded in 1982 and KOSDAQ-listed in 2008, Sewoon Medical manufactures medical aspirators and catheters/tubes.

Bistos Co., Ltd.2 shared

Founded in 2001 and KOSDAQ-listed in 2022, Bistos manufactures fetal, neonatal, and patient monitoring medical devices.

SELVAS Healthcare, Inc.2 shared

SELVAS Healthcare operates the ACCUNIQ medical diagnostic device brand and the HIMS assistive technology device brand.

Yuyu Pharma, Inc.2 shared

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition